116 related articles for article (PubMed ID: 38862693)
21. Identification of Tumor Suppressive Genes Regulated by
Oshima S; Asai S; Seki N; Minemura C; Kinoshita T; Goto Y; Kikkawa N; Moriya S; Kasamatsu A; Hanazawa T; Uzawa K
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201353
[TBL] [Abstract][Full Text] [Related]
22. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.
Guo YZ; Sun HH; Wang XT; Wang MT
J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634
[TBL] [Abstract][Full Text] [Related]
23. Co-expression network-based identification of biomarkers correlated with the lymph node metastasis of patients with head and neck squamous cell carcinoma.
Jin Y; Qin X
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32076707
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
25. Specificity protein 1/microRNA-92b forms a feedback loop promoting the migration and invasion of head and neck squamous cell carcinoma.
Pang P; Fang H; Wu H; Wang S; Liu M; Jin S; Qi Z; Li Z; Liu F; Sun C
Bioengineered; 2021 Dec; 12(2):11397-11409. PubMed ID: 34905435
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
[TBL] [Abstract][Full Text] [Related]
27. Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma.
Zhou Z; Wu W; Li J; Liu C; Xiao Z; Lai Q; Qin R; Shen M; Shi S; Kang M
BMC Cancer; 2021 Apr; 21(1):395. PubMed ID: 33845800
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma.
He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H
Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150
[TBL] [Abstract][Full Text] [Related]
29. HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis.
Yin X; Yang W; Xie J; Wei Z; Tang C; Song C; Wang Y; Cai Y; Xu W; Han W
Biomed Res Int; 2019; 2019():5450617. PubMed ID: 31032351
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
[TBL] [Abstract][Full Text] [Related]
31. Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma.
Yang P; Huang G; Li Y; Yu L; Yin Z; Li Q
Sci Rep; 2024 Apr; 14(1):9824. PubMed ID: 38684755
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR-421 and E-cadherin.
Ji Y; Feng G; Hou Y; Yu Y; Wang R; Yuan H
Cancer Med; 2020 Jun; 9(11):3954-3963. PubMed ID: 32277605
[TBL] [Abstract][Full Text] [Related]
33. Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis.
Yang K; Zhang S; Zhang D; Tao Q; Zhang T; Liu G; Liu X; Zhao T
Int J Clin Oncol; 2019 Sep; 24(9):1030-1041. PubMed ID: 30937621
[TBL] [Abstract][Full Text] [Related]
34. Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma.
Li C; Wu ZH; Yuan K
Dis Markers; 2020; 2020():8899337. PubMed ID: 33133307
[TBL] [Abstract][Full Text] [Related]
35. Identification of hub genes and potential therapeutic mechanisms related to HPV positive head and neck squamous carcinoma based on full transcriptomic detection and ceRNA network construction.
Wang K; Zhang T; Li X; Zhang X; Li R; Pan B; Deng J
Gene; 2024 Jun; 910():148321. PubMed ID: 38428621
[TBL] [Abstract][Full Text] [Related]
36. Long non‑coding RNA MIR4435‑2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR‑383‑5p/RBM3 axis.
Wang S; Chen X; Qiao T
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846802
[TBL] [Abstract][Full Text] [Related]
37. The impact of LncRNA-SOX2-OT/let-7c-3p/SKP2 Axis on head and neck squamous cell carcinoma progression: Insights from bioinformatics analysis and experimental validation.
Wang D; Zhao X; Li S; Guo H; Li S; Yu D
Cell Signal; 2024 Mar; 115():111018. PubMed ID: 38110167
[TBL] [Abstract][Full Text] [Related]
38. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
39. Identification of ACAA1 and HADHB as potential prognostic biomarkers based on a novel fatty acid oxidation-related gene model in head and neck squamous cell carcinoma: A retrospective study.
Wang WL; Jiang HJ; Shen ZL; Tang YL; Jiang J; Liang XH
Arch Oral Biol; 2024 Jul; 163():105982. PubMed ID: 38678878
[TBL] [Abstract][Full Text] [Related]
40. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma.
Mao R; Chen Y; Xiong L; Liu Y; Zhang T
Aging (Albany NY); 2020 Oct; 12(20):20778-20800. PubMed ID: 33091878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]